罕见病知识库 RareSeen

家族性腺瘤性息肉病

Familial adenomatous polyposis

定义 英文原文(暂无中文)

A rare intestinal polyposis syndrome characterized by the development of up to hundreds to thousands of adenomas in the large bowel. It is a multi-system disorder with important extracolonic manifestations.

别名

结直肠腺瘤性息肉病

基本事实

遗传方式
常染色体显性、常染色体隐性
发病年龄
成年期
患病率
1-9 / 100 000

相关基因 1

基因名称关联类型
APCAPC regulator of Wnt signaling pathwayDisease-causing germline mutation(s) in

临床表型 45

极常见 99–80%6

  • 腺瘤性结肠息肉病 HP:0005227
  • 结肠癌 HP:0003003
  • 结直肠息肉病 HP:0200063
  • 先天性视网膜色素上皮肥大 HP:0007649
  • 胃肠道硬纤维瘤 HP:0100245
  • 胃肠道新生物 HP:0007378

常见 79–30%7

  • 牙列异常 HP:0000164
  • 便秘 HP:0002019
  • 腹泻 HP:0002014
  • 十二指肠息肉 HP:0004783
  • 多发性胃息肉 HP:0004394
  • 骨瘤 HP:0100246
  • 甲状腺结节 HP:0025388

偶见 29–5%10

  • 牙骨质形态异常 HP:0100717
  • 甲状腺异常 HP:0000820
  • 肾上腺皮质腺瘤 HP:0008256
  • 血管纤维瘤 HP:0010615
  • 十二指肠腺癌 HP:0006771
  • 肾上腺肿瘤 HP:0100631
  • 牙瘤 HP:0011068
  • 甲状腺乳头状癌 HP:0002895
  • 多生牙 HP:0011069
  • 牙萌出失败 HP:0000706

罕见 <4–1%22

  • 小肠腺癌 HP:0040274
  • 星形细胞瘤 HP:0009592
  • 胆道梗阻 HP:0005230
  • 脑肿瘤 HP:0030692
  • 胆管癌 HP:0030153
  • 室管膜瘤 HP:0002888
  • 表皮样囊肿 HP:0200040
  • 纤维瘤 HP:0010614
  • 甲状腺肿 HP:0000853
  • 肝母细胞瘤 HP:0002884
  • 甲状腺功能减退症 HP:0000821
  • 脂肪瘤 HP:0012032
  • 局限性皮损 HP:0011355
  • 髓母细胞瘤 HP:0002885
  • 胆囊新生物 HP:0100575
  • 胰腺腺癌 HP:0006725
  • 胰腺炎 HP:0001733
  • 毛母质瘤 HP:0030434
  • 垂体腺瘤 HP:0002893
  • 软组织肿瘤 HP:0031459
  • 胃癌 HP:0012126
  • 甲状腺炎 HP:0100646

近两年的全球研究 2,225L2

2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。

  • 2026-10
    Abstracts
    JPGN reports
  • 2026-10荟萃分析系统综述开放获取
    Enhanced recovery after colorectal surgery in patients with inflammatory bowel disease to reduce hospital length of stay: A systematic review and meta-analysis
    Colorectal disease : the official journal of the Association of Colopr · DOI · Europe PMC
  • 2026-10
    Support for Disclosure of Hereditary Tumor Risk to Children and Adolescents: A Scoping Review
    Japan journal of nursing science : JJNS · DOI · Europe PMC
  • 2026-10综述
    Approaches to thyroid nodules in paediatric cancer predisposition syndromes
    European thyroid journal · DOI · Europe PMC
  • 2026-09
    Invited Commentary on: Comparison of the outcomes of ileal pouch-anal anastomosis and ileorectal anastomosis for patients with familial adenomatous polyposis: A systematic review and meta-analysis
    Journal of gastrointestinal surgery : official journal of the Society · DOI · Europe PMC
  • 2026-09开放获取
    Development of an Interpretable Triage Tool for Colorectal Polyp Risk Stratification Within a Population-Based Screening Program: Machine Learning Approach
    JMIR medical informatics · DOI · Europe PMC
  • 2026-09开放获取
    Rapidly Progressive Metastatic Sertoli Cell Tumor Associated With an Adenomatous Polyposis Coli Mutation: A Case Report and Literature Review
    IJU case reports · DOI · Europe PMC
  • 2026-09综述开放获取
    Engineering Functional Biomaterials for Targeted and Localized Cancer Drug Delivery: A Structure-Property-Performance Design Perspective
    Pharmaceuticals (Basel, Switzerland) · DOI · Europe PMC
  • 2026-09
    Molecular surgery in colorectal cancer: Integrating genomics into operative decision-making
    European journal of surgical oncology : the journal of the European So · DOI · Europe PMC
  • 2026-09开放获取
    Somatic Mutation Profile in Normal Tissue Adjacent to Tumor in Colorectal Carcinoma Patients: Functional Effect on Gene Expression and Potential Implications for Precision Medicine
    Cancers · DOI · Europe PMC
  • 2026-09
    Life expectancy and changing causes of mortality in familial adenomatous polyposis (FAP)
    The American journal of gastroenterology · DOI · Europe PMC
  • 2026-09开放获取
    Levofloxacin enhances 5-fluorouracil efficacy in colorectal cancer by activating the DDR-TP53-mitochondrial apoptosis axis
    iScience
  • 2026-09综述开放获取
    Villous Architecture in Colorectal Adenomas: Molecular Pathogenesis, Epithelial Plasticity, and Malignant Risk
    Cells · DOI · Europe PMC
  • 2026-09开放获取
    Health technology assessment of robotic surgery for rectal cancer in China: protocol for a nationally multicentre prospective cohort study
    BMJ open · DOI · Europe PMC
  • 2026-09
    Risk of desmoid tumor based on APC pathogenic variant location and surgical history in familial adenomatous polyposis: a U.S. community cohort study
    Familial cancer · DOI · Europe PMC
  • 2026-09病例报告开放获取
    Concomitant parathyroid hormone-secreting oncocytic adrenocortical carcinoma and parathyroid adenoma
    JCEM case reports · DOI · Europe PMC
  • 2026-09综述开放获取
    Essential Updates in the Surgical Management of Inflammatory Bowel Disease: Current Topics From 2024 to Mid‐2026
    Annals of gastroenterological surgery
  • 2026-09综述开放获取
    Role of tumor necrosis factor receptor superfamily member 19 in cancer: Diverse functions and therapeutic potential (Review)
    Oncology letters · DOI · Europe PMC
  • 2026-09开放获取
    Intensive Endoscopic Resection for Downstaging of Superficial Non-ampullary Duodenal Epithelial Tumor Burden in Familial Adenomatous Polyposis: A Single-center Retrospective Study on Long-term Clinical Outcome
    DEN open · DOI · Europe PMC
  • 2026-09综述开放获取
    Bridging pediatric and adult neuro-oncology: Insights into adolescents and young adults (AYA) central nervous system tumors
    Neurotherapeutics : the journal of the American Society for Experiment · DOI · Europe PMC

境外已获批用于本病的药物 0L2

欧盟与美国均未检索到已获批用于本病的药物。

尚未获批的在研药物(17 项)

这些药已被欧盟或美国的监管机构认定为罕见病用药(英文 orphan drug designation,中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领,不是在说病人)。但这只是一种监管身份:意味着监管机构给予研发上的激励,不代表这个药已被证明有效,也不代表将来一定能上市,绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。

  • Eicosapentaenoic acid欧盟2009-10-08
    Treatment of familial adenomatous polyposis (FAP)
    官方记录
  • eflornithine欧盟2010-09-20
    Treatment of familial adenomatous polyposis (FAP)
    官方记录
  • (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-欧盟2022-07-18
    Treatment of familial adenomatous polyposis (FAP)
    官方记录
  • Lithium carbonate欧盟2022-08-10
    Treatment of familial adenomatous polyposis (FAP)
    官方记录
  • sirolimus欧盟2025-04-16
    Treatment of familial adenomatous polyposis (FAP)
    官方记录
  • live attenuated E. Coli expressing Beta catenin shRNA美国2010-12-20
    Treatment of Familial Adenomatous Polyposis
    官方记录
  • eflornithine美国2011-02-04
    Treatment of Familial Adenomatous Polyposis
    官方记录
  • eicosapentaenoic acid美国2011-03-08
    Treatment of familial adenomatous polyposis
    官方记录
  • eflornithine plus sulindac美国2013-01-22
    Treatment of familial adenomatous polyposis
    官方记录
  • pyrvinium美国2015-01-05
    Treatment of familial adenomatous polyposis
    官方记录
  • magnesium lysinate bis eicosapentaenoate美国2015-12-23
    Treatment of familial adenomatous polyposis.
    官方记录
  • encapsulated rapamycin美国2019-03-15
    Treatment of familial adenomatous polyposis
    官方记录
  • 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]美国2021-09-28
    Treatment of familial adenomatous polyposis
    官方记录
  • Microencapsulated Interleukin-10美国2023-09-05
    Treatment of Familial Adenomatous Polyposis
    官方记录
  • beta-catenin antagonist美国2024-12-10
    treatment of familial adenomatous polyposis
    官方记录
  • selective dual antagonist of the human prostaglandin E2 (PGE2) recepto美国2025-03-31
    treatment of familial adenomatous polyposis (FAP)
    官方记录
  • potent, ATP-competitive small molecule inhibitor of glycogen synthase 美国2026-05-22
    treatment of familial adenomatous polyposis
    官方记录

数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。

在中国开展的临床试验 4L2

按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实,并与主治医生商量。

登记为可入组 2

  • 尚未开始招募NCT04531930
    Colorectal Adenoma Canceration in FAP
    观察性 · 2020/10/01Changhai Hospital
    中国研究中心 1 个:Shanghai
  • 仅邀请入组NCT06649825
    Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.
    不适用 · 干预性 · 2024/01/08Shanghai Zhongshan Hospital
    中国研究中心 1 个:Shanghai
其他状态的试验(2 项)
  • 已完成NCT03333265
    Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride
    II 期、III 期 · 干预性 · 2017/09/01Xijing Hospital of Digestive Diseases
    中国研究中心 1 个:Xi'an
  • 已完成NCT05687318
    A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment
    不适用 · 干预性 · 2022/09/20Peking Union Medical College Hospital
    中国研究中心 1 个:Beijing

中国境外的在招试验 22L2

这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。

美国11法国3荷兰3丹麦2意大利2澳大利亚2英国1德国1Puerto Rico1西班牙1巴西1

CT.gov 报告命中 22 项,此处取回并展示最近的 15 项。

  • 尚未开始招募NCT07729371
    A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
    I 期 · 干预性 · 2027/01/04Sapience Therapeutics
  • 尚未开始招募NCT06308445
    Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis
    II 期 · 干预性 · 2026/09/01University Hospital, Toulouse
    法国
  • 招募中NCT07726771
    Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)
    不适用 · 干预性 · 2026/07/09London North West Healthcare NHS Trust
    英国
  • 招募中NCT06641310
    Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
    不适用 · 干预性 · 2026/05/13University of Michigan Rogel Cancer Center
    美国
  • 招募中NCT06557733
    An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
    II 期 · 干预性 · 2026/03/31National Cancer Institute (NCI)
    美国
  • 尚未开始招募NCT06881303
    Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion
    不适用 · 干预性 · 2026/03/01Assistance Publique Hopitaux De Marseille
    法国
  • 招募中NCT07463599
    Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
    I 期、II 期 · 干预性 · 2026/02/17HonorHealth Research Institute
    美国
  • 招募中NCT05630794
    Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
    I 期 · 干预性 · 2025/10/06National Cancer Institute (NCI)
    美国
  • 招募中NCT06950385
    Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
    III 期 · 干预性 · 2025/07/18Rapamycin Holdings Inc.
    丹麦、德国、意大利、荷兰、Puerto Rico、西班牙、美国
  • 招募中NCT06538402
    Ten Versus Fifteen Centimeter Pouch in IPAA Surgery
    不适用 · 干预性 · 2025/07/03Odense University Hospital
    丹麦
  • 招募中NCT07066046
    Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions
    不适用 · 干预性 · 2025/02/01Instituto do Cancer do Estado de São Paulo
    巴西
  • 招募中NCT06614738
    Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)
    观察性 · 2024/12/17Hospices Civils de Lyon
    法国
  • 招募中NCT05552755
    Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
    I 期、II 期 · 干预性 · 2023/07/10Recursion Pharmaceuticals Inc.
    美国
  • 招募中NCT05919264
    FOG-001 in Locally Advanced or Metastatic Solid Tumors
    I 期、II 期 · 干预性 · 2023/05/23Parabilis Medicines, Inc.
    澳大利亚、美国
  • 招募中NCT04678011
    A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
    观察性 · 2021/11/24Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
    荷兰、美国

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)